Encompass Health (NYSE:EHC) Issues FY24 Earnings Guidance

Encompass Health (NYSE:EHC) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided EPS guidance of $3.86-4.11 for the period, compared to the consensus EPS estimate of $3.98. The company issued revenue guidance of $5.250-5.325 billion, compared to the consensus revenue estimate of $5.25 billion.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Truist Financial boosted their target price on Encompass Health from $82.00 to $86.00 and gave the stock a buy rating in a report on Friday, February 9th. Mizuho upped their price target on Encompass Health from $93.00 to $95.00 and gave the stock a buy rating in a report on Thursday. Stephens reiterated an overweight rating and set a $85.00 price target on shares of Encompass Health in a report on Tuesday, January 16th. Raymond James restated a strong-buy rating and set a $95.00 price objective (up from $85.00) on shares of Encompass Health in a research report on Friday. Finally, Royal Bank of Canada restated an outperform rating and set a $83.00 price objective on shares of Encompass Health in a research report on Friday, February 9th. Eight investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of Buy and an average price target of $86.56.

Encompass Health Price Performance

Shares of EHC stock traded down $0.26 during trading hours on Friday, hitting $82.47. 706,619 shares of the company’s stock were exchanged, compared to its average volume of 756,857. The stock’s 50-day moving average is $78.25 and its 200-day moving average is $70.87. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.37 and a quick ratio of 1.28. The stock has a market cap of $8.26 billion, a price-to-earnings ratio of 22.29, a price-to-earnings-growth ratio of 1.50 and a beta of 0.94. Encompass Health has a 52 week low of $57.55 and a 52 week high of $85.84.

Encompass Health (NYSE:EHC) last announced its earnings results on Wednesday, April 24th. The company reported $1.12 EPS for the quarter, topping the consensus estimate of $0.93 by $0.19. The company had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.27 billion. Encompass Health had a return on equity of 18.01% and a net margin of 7.60%. The business’s revenue for the quarter was up 13.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.88 earnings per share. As a group, research analysts forecast that Encompass Health will post 4.04 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.73%. The ex-dividend date was Thursday, March 28th. Encompass Health’s dividend payout ratio (DPR) is presently 16.22%.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.